LECZENIE ZABURZEŃ SEKSUALNYCH U OSÓB Z CHOROBĄ NIEDOKRWIENNĄ SERCA.

The paper presents some basic data on treating patients with coronary heart disease and sexual dysfunctions. It is reported the opinion of the Second Princeton Consensus Panel (2005). Erectile dysfunction may be the earliest syndrome of cardiovascular disease. Patients after myocardial infarction feel grat prejudice while returning to their sexual activity. Patients fears are an important problem for cardiologist. Discussed reports show correlation between sudden death and taking cardiological medications with PDE-5 inhibitors at the same time. Sildenafil is recommended for men with erectile dysfunction and heart dissease. PDE-5 inhibitors should not be used in combination with alpha-blockers. Patients treated with nitrates should not take sildenafil and vardenafil in 24 hours, and tadalafil in 48 hours after a nitrate. The interactions between cardiological medications and phosphodiesterase-5 inhibitors are also disscused. [ABSTRACT FROM AUTHOR]